Denali Therapeutics
Denali Therapeutics70About
What does Denali Therapeutics do?
Denali Therapeutics is a biopharmaceutical company focused on discovering, developing, and delivering medicines for people living with serious diseases, particularly neurodegenerative conditions. Their core strategy involves creating therapies that can effectively cross the blood-brain barrier using their proprietary Transport Vehicle (TV) technology. The company aims to address debilitating conditions such as Alzheimer's, Parkinson's, and ALS.
What is Denali Therapeutics's revenue?
StartupHub estimates Denali Therapeutics's annual revenue at $80.6M (range $45.3M to $453.5M, 28% confidence), based on comparable companies in the sector.
What is Denali Therapeutics's valuation?
StartupHub estimates Denali Therapeutics's effective valuation at $4.6B (range $2.6B to $6.3B, 21% confidence), based on comparable companies in the sector.
How much funding has Denali Therapeutics raised?
Denali Therapeutics has raised a total of $1.0B in funding. The most recent round on record is Royalty Funding.
Where is Denali Therapeutics headquartered?
Denali Therapeutics is headquartered in South San Francisco, United States.
When was Denali Therapeutics founded?
Denali Therapeutics was founded in 2015.
What industry does Denali Therapeutics operate in?
Denali Therapeutics operates in Biotech, HealthTech, Drug Discovery, Neurotech, Biopharmaceutical, Therapeutics.
No comments yet. Be the first to share your take.